Smith Anglin Financial LLC Sells 74 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Smith Anglin Financial LLC cut its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 6.9% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,003 shares of the healthcare conglomerate’s stock after selling 74 shares during the period. Smith Anglin Financial LLC’s holdings in UnitedHealth Group were worth $525,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. NewSquare Capital LLC acquired a new stake in shares of UnitedHealth Group during the 4th quarter worth approximately $25,000. Marshall & Sterling Wealth Advisors Inc. acquired a new stake in UnitedHealth Group in the fourth quarter worth $26,000. Hurley Capital LLC acquired a new position in shares of UnitedHealth Group during the fourth quarter valued at about $28,000. Aster Capital Management DIFC Ltd acquired a new stake in shares of UnitedHealth Group in the 4th quarter valued at about $30,000. Finally, Promus Capital LLC acquired a new stake in UnitedHealth Group in the fourth quarter valued at approximately $32,000. Institutional investors own 87.86% of the company’s stock.

Insider Activity at UnitedHealth Group

In other news, Director Kristen Gil purchased 3,700 shares of the stock in a transaction dated Thursday, May 15th. The shares were purchased at an average cost of $271.17 per share, with a total value of $1,003,329.00. Following the completion of the acquisition, the director now owns 3,818 shares in the company, valued at $1,035,327.06. This represents a 3,135.59% increase in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director John H. Noseworthy bought 300 shares of the firm’s stock in a transaction that occurred on Wednesday, May 14th. The shares were purchased at an average cost of $312.16 per share, for a total transaction of $93,648.00. Following the acquisition, the director now directly owns 6,063 shares in the company, valued at $1,892,626.08. This trade represents a 5.21% increase in their position. The disclosure for this purchase can be found here. In the last ninety days, insiders acquired 109,408 shares of company stock worth $31,607,768. Corporate insiders own 0.33% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have weighed in on the stock. Deutsche Bank Aktiengesellschaft dropped their price objective on shares of UnitedHealth Group from $521.00 to $362.00 and set a “buy” rating on the stock in a research note on Wednesday, May 14th. Barclays decreased their price objective on UnitedHealth Group to $350.00 and set an “overweight” rating for the company in a report on Monday. TD Cowen cut UnitedHealth Group from a “buy” rating to a “hold” rating and set a $308.00 target price on the stock. in a research report on Monday, May 19th. Erste Group Bank lowered UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, April 30th. Finally, Raymond James lowered shares of UnitedHealth Group from a “strong-buy” rating to a “market perform” rating in a research note on Wednesday, May 14th. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating and seventeen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, UnitedHealth Group presently has an average rating of “Moderate Buy” and an average target price of $439.17.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $304.27 on Tuesday. UnitedHealth Group Incorporated has a 1 year low of $248.88 and a 1 year high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The business has a fifty day simple moving average of $426.60 and a two-hundred day simple moving average of $490.74. The company has a market capitalization of $276.01 billion, a P/E ratio of 19.63, a P/E/G ratio of 1.37 and a beta of 0.56.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). The business had revenue of $109.58 billion for the quarter, compared to analysts’ expectations of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same period last year, the company earned $6.91 earnings per share. On average, analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.